Nutrition for infants with ileostomy
Correlation Between Enteral Nutrition and Early Prognosis in Infants Aged Under 6 Months Following Enterostomy
This study looks at how feeding infants with an ileostomy, especially with breast milk, affects their growth and health in the first six months of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 110 (estimated) |
| Ages | N/A to 6 Months |
| Sex | All |
| Sponsor | Children's Hospital of Fudan University Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Trial ID | NCT04707443 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on infants aged 0-6 months who have undergone small bowel ostomy due to various medical conditions. It aims to evaluate the nutritional outcomes of these infants, particularly the benefits of breast milk compared to other feeding options. The study will monitor complications related to enterostomy, such as infections and nutrient deficiencies, and assess the impact of early breastfeeding on recovery and growth. By analyzing the feeding tolerance and nutritional status of these infants, the study seeks to improve care practices in pediatric gastroenterology.
Who should consider this trial
Good fit: Ideal candidates for this study are infants aged 0-6 months who have undergone small bowel ostomy.
Not a fit: Patients with primary liver and kidney dysfunction or congenital multiple malformations and chromosomal abnormalities may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance nutritional strategies for infants with ileostomy, potentially improving their health outcomes and quality of life.
How similar studies have performed: Previous studies have shown the benefits of breast milk in similar populations, indicating a promising approach for this study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * After birth, infants aged 0-6 months (including neonates) undergo small bowel ostomy for various reasons. Exclusion Criteria: * Primary liver and kidney dysfunction, congenital multiple malformations and chromosomal abnormalities.
Where this trial is running
Shanghai, Shanghai Municipality
- Children's Hospital of Fudan University — Shanghai, Shanghai Municipality, China (Recruiting)
Study contacts
- Study coordinator: Tian Qian, M.D.
- Email: drqiantian@fudan.edu.cn
- Phone: 02164931981
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.